Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Metzler

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Familial Cancer|September 5, 2020
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working GroupSimone Hettmer, Guillaume Dachy, Guido Seitz, et al.
Blood|June 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphomaFabian Müller, Nora Rebecca Schwingen, Melanie Hagen, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
Pediatric Blood & Cancer|November 18, 2015
Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition SyndromesMarie L Weber, Dominik T Schneider, Sonja Offenmüller, et al.
British Journal of Haematology|May 9, 2025
Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterationsYvonne Lisa Behrens, Thea Reinkens, Winfried Hofmann, et al.
Leukemia|January 27, 2023
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendationsStephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
British Journal of Haematology|March 29, 2014
DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemiaNaomi E van der Sligte, Manuela Krumbholz, Agata Pastorczak, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Familial Cancer|September 5, 2020
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working GroupSimone Hettmer, Guillaume Dachy, Guido Seitz, et al.
Blood|June 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphomaFabian Müller, Nora Rebecca Schwingen, Melanie Hagen, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
Pediatric Blood & Cancer|November 18, 2015
Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition SyndromesMarie L Weber, Dominik T Schneider, Sonja Offenmüller, et al.
British Journal of Haematology|May 9, 2025
Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterationsYvonne Lisa Behrens, Thea Reinkens, Winfried Hofmann, et al.
Leukemia|January 27, 2023
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendationsStephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
British Journal of Haematology|March 29, 2014
DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemiaNaomi E van der Sligte, Manuela Krumbholz, Agata Pastorczak, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Pageof 18